Kumaran Vinay, Joseph Brigid, Benten Daniel, Gupta Sanjeev
Department of Medicine, Marion Bessin Liver Research Center, Cancer Research Center, Diabetes Research Center, and General Clinical Research Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
Gastroenterology. 2005 Nov;129(5):1643-53. doi: 10.1053/j.gastro.2005.08.006.
BACKGROUND & AIMS: Recognition and circumvention of the hepatic endothelial barrier is critical in the engraftment of transplanted cells. We examined whether interactions between integrin and extracellular matrix component receptors could be manipulated for improving transplanted cell engraftment and liver repopulation.
Fischer 344 rat hepatocytes were transplanted into syngeneic dipeptidyl peptidase IV-deficient rats. Coating of cells or of liver sinusoids with natural collagen, natural laminin, or an engineered fibronectin-like polymer was studied with analysis of cell engraftment and liver repopulation using histologic and molecular assays. Focal adhesion complexes were identified by vinculin immunostaining. The role of integrin receptors in cell engraftment was analyzed with RGD peptide inhibition assays.
Coating of cells with extracellular matrix components before transplantation did not enhance cell engraftment. In contrast, intraportal infusion of collagen or fibronectin-like polymer in recipients prior to cell transplantation increased cell engraftment. Adherence of transplanted cells to the hepatic endothelium resulted in rapid activation of vinculin-containing focal adhesion complexes. Superior cell engraftment in animals treated with fibronectin-like polymer was RGD sensitive, verifying the integrin-dependent nature of this process. Moreover, studies in the retrorsine-partial hepatectomy rat model showed that intraportal infusion of the fibronectin-like polymer before cell transplantation significantly accelerated liver repopulation.
Integrin-extracellular matrix component interactions can be manipulated for enhancing cell engraftment in the liver. Such mechanisms will be relevant for engraftment of other cell types and for strategies concerning liver-directed cell therapy.
识别并规避肝内皮屏障对于移植细胞的植入至关重要。我们研究了整合素与细胞外基质成分受体之间的相互作用是否可以被调控,以改善移植细胞的植入和肝脏再填充。
将Fischer 344大鼠肝细胞移植到同基因的二肽基肽酶IV缺陷大鼠体内。通过组织学和分子分析方法,研究用天然胶原蛋白、天然层粘连蛋白或一种工程化的类纤连蛋白聚合物包被细胞或肝血窦对细胞植入和肝脏再填充的影响。通过纽蛋白免疫染色鉴定粘着斑复合物。用RGD肽抑制试验分析整合素受体在细胞植入中的作用。
移植前用细胞外基质成分包被细胞并不能增强细胞植入。相反,在细胞移植前向受体门静脉内输注胶原蛋白或类纤连蛋白聚合物可增加细胞植入。移植细胞与肝内皮的粘附导致含纽蛋白的粘着斑复合物迅速激活。用类纤连蛋白聚合物处理的动物中更好的细胞植入对RGD敏感,证实了该过程依赖整合素的性质。此外,在倒千里光碱-部分肝切除大鼠模型中的研究表明,细胞移植前门静脉内输注类纤连蛋白聚合物可显著加速肝脏再填充。
可以调控整合素-细胞外基质成分之间的相互作用以增强细胞在肝脏中的植入。此类机制将与其他细胞类型的植入以及肝脏定向细胞治疗策略相关。